Microlyte in Prevention of SSI After Open Ventral Hernia Repair

Status Withdrawn

Clinical Trial Summary

Participants who are scheduled to have open ventral hernia repair (OVHR) will be asked to take part in this study. The purpose of this study is to find out if placing Microlyte (which is a dissolvable sheet coated in silver) on the surgical incision is better than placing nothing on the surgical incision when it comes to decreasing the chance of surgical site infections. The study device has been cleared by the Food and Drug Administration (FDA) for use on surgical incisions. A total of 280 participants will be included in the study. Participation will last for about 90 days.

Clinical Trial Description

The aim of our study is to assess the impact of Microlyte-AG® (Imbed Biosciences, Fitchburg, WI), a silver-coated bioabsorbable matrix, on surgical site infection (SSI) on patients undergoing clean open ventral hernia repair (OVHR) at Carolinas Medical Center/Atrium Health (Charlotte, NC), Prisma Health-Upstate (Greenville, SC), and Mission Health/HCA Healthcare (Asheville, NC). Those who agree to participate in the study will undergo the following: Information will be collected, including demographics, past medical and surgical history, and hospital outcomes. On the day of surgery, participants will be "randomized" into one of the study groups listed below. - Group 1: The study device will be cut into strips and placed in the surgical incision - Group 2: Nothing will be placed in the surgical incision For both groups, the surgical incision will then be closed with absorbable sutures, which is the usual treatment. Participants will be seen by the study doctor 30 and 90 days after surgery for a checkup. At the 30-day visit, participants will have a physical examination, and the study doctor will check to see if any complications have happened since the last visit. The 90-day follow-up visit can be done in person or over the telephone and will be done to check and see if there have been any problems with the healing of the surgical incision. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05093894
Study type	Interventional
Source	Prisma Health-Upstate
Contact
Status	Withdrawn
Phase	N/A
Start date	December 14, 2021
Completion date	October 6, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06016426` - Mass Closure vs Layer by Layer Closure	N/A
Recruiting	`NCT05572021` - A Comparison of the Outcomes in Fortiva and Strattice Mesh	N/A
Completed	`NCT02263625` - Regional Differences In Indication for Ventral Hernia Repair
Completed	`NCT02263599` - Conservative Treatment For Ventral Hernia
Completed	`NCT02292264` - Risk Factors and Complications of Ventral Hernia Repair
Completed	`NCT01961687` - A Prospective, Multi-Center Study of Phasix™ Mesh for Ventral or Incisional Hernia Repair.	N/A
Completed	`NCT01325246` - Reoperation Rate Versus Clinical Recurrence After Ventral Hernia Repair	N/A
Completed	`NCT03283982` - Laparoscopic vs. Robotic Ventral Hernia Repair With IPOM	N/A
Not yet recruiting	`NCT05526209` - Longitudinal Relaxing Incision as a Technique for Recurrence Prevention in Ventral Hernia
Completed	`NCT04438369` - Evaluation of Ultrasound-guided Erector Spinae Block for Postoperative Analgesia in Laprascopic Ventral Hernia Repair.	N/A
Recruiting	`NCT04173884` - Video-based Collaborative Learning to Improve Ventral Hernia Repair	N/A
Recruiting	`NCT02703662` - Performance of Biologic Mesh Materials in Abdominal Wall Reconstruction	Phase 2/Phase 3
Completed	`NCT03938688` - Randomized Control Trial Comparing Transfascial Suture for Mesh Fixation to No Mesh Fixation	N/A
Completed	`NCT01719718` - The Influence of Closing the Gap on Postoperative Seroma and Recurrences in Laparoscopic Ventral Hernia Repair	N/A
Completed	`NCT03342040` - Transverse Abdominis Plane Block in Laparoscopic Ventral Hernia Repair	N/A
Completed	`NCT04150796` - Comparing eTEP and Laparoscopic Intraperitoneal Onlay Mesh (IPOM) for Ventral Hernias	N/A
Recruiting	`NCT03222102` - Ventral Hernia Prevention After Liver Transplantation	N/A
Completed	`NCT05610267` - Gentrix® Surgical Matrix for Soft Tissue Reinforcement in Ventral Hernia Repair
Terminated	`NCT01794338` - The Use of Biologic Mesh vs Bioabsorbable Mesh During Ventral Hernia Repair in At-risk Patients	N/A
Completed	`NCT01886963` - A Clinical Trial Using Spy Elite System in Planning Tissue Advancement Flaps After Ventral Hernia Repair	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.